Obesidad y Cáncer
OBECAN
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (10)
2024
-
Epicardial and liver fat implications in albuminuria: a retrospective study
Cardiovascular Diabetology, Vol. 23, Núm. 1
2023
-
Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function
Molecular Metabolism, Vol. 75
-
Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism
Cell Metabolism, Vol. 35, Núm. 9, pp. 1630-1645.e5
2022
-
Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
Frontiers in Medicine, Vol. 9
-
Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD
Scientific Reports, Vol. 12, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
O-GlcNAcylated p53 in the liver modulates hepatic glucose production
Nature Communications, Vol. 12, Núm. 1
-
Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points
Journal of Hepatology
2020
-
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD
FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837
2016
-
Factors related to increased resting energy expenditure in men with liver cirrhosis
European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145